Preview

Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH)

Advanced search
Fullscreen

For citations:


Cherenova S.G., Rubanenko O.A., Rubanenko A.O., Lomaia E.G., Turkina A.G., Davydkin I.L. Development of cardiovascular toxicity in patients with chronic myeloid leukemia treated with the second-generation tyrosine kinase inhibitor bozutinib. Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH). 2025;15(5):149-156. (In Russ.) https://doi.org/10.20340/vmi-rvz.2025.5.CLIN.14

Views PDF (Rus): 5

JATS XML


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2226-762X (Print)
ISSN 2782-1579 (Online)